B
Beyond Verbal
Beyond Verbal is committed to identifying proprietary Vocal Biomarkers for personalized healthcare screening & monitoring based on voice
About Beyond Verbal
Beyond Verbal operates in the health technology sector, specializing in voice analysis to monitor and detect health conditions. The company serves healthcare providers, researchers, and technology integrators by offering a software solution that runs on all voice platforms. Beyond Verbal's core product leverages proprietary AI and big data analytics to identify vocal biomarkers, which are unique voice patterns that can indicate health status. The business model revolves around licensing its Vocalis API to clients, enabling them to integrate voice analysis capabilities into their own systems. Revenue is generated through subscription fees and data analytics services. The company aims to be an early adopter in the commercialization of vocal biomarkers, providing actionable insights to care teams for better health monitoring and risk assessment.
Source: Dealroom company dataAt a glance
- Founded
- 2012
- Headquarters
- Tel Aviv-Yafo, Israel
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Winnovation- OMOmninet
Series A3 investors entered at this stage
- KSKuang-Chi Science
Singulariteam
Kuang-Chi GCI Fund & Incubator
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beyond Verbal on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beyond Verbal on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.